Hence, unlike TNBC, in which the balance of the strongest age-dependent signaling interactions tipped in favor of the older cohort, interactions were more evenly balanced between older and younger cohorts in the ER+ breast cancers. The gene discussed is ESR1; the disease is breast carcinoma.